Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · Real-Time Price · USD
0.567
-0.023 (-3.85%)
At close: Nov 22, 2024, 4:00 PM
0.500
-0.067 (-11.82%)
After-hours: Nov 22, 2024, 7:59 PM EST
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $2.77 million as of November 22, 2024. Its market cap has decreased by -70.05% in one year.
Market Cap
2.77M
Enterprise Value
2.86M
1-Year Change
-70.05%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since the IPO on February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from $45.09M to $2.77M, a decrease of -93.85%. That is a compound annual growth rate of -52.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 3.02M | -19.58% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | -10.88% |
| Feb 17, 2021 | 45.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Titan Pharmaceuticals | 3.34M |
| Palisade Bio | 3.24M |
| Quoin Pharmaceuticals | 3.16M |
| Enveric Biosciences | 3.12M |
| Processa Pharmaceuticals | 2.96M |
| Aditxt | 2.96M |
| Bio-Path Holdings | 2.92M |
| Lipella Pharmaceuticals | 2.91M |